Product Name

  • Name

    Pitavastatin

  • EINECS
  • CAS No. 147511-69-1
  • Article Data16
  • CAS DataBase
  • Density 1.352 g/cm3
  • Solubility
  • Melting Point
  • Formula C25H24FNO4
  • Boiling Point 691.961 °C at 760 mmHg
  • Molecular Weight 421.468
  • Flash Point 372.285 °C
  • Transport Information
  • Appearance
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 147511-69-1 (Pitavastatin)
  • Hazard Symbols
  • Synonyms 6-Heptenoicacid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-,[S-[R*,S*-(E)]]-;(+)-(3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydroxy-6-heptenoicacid;(3R,5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoicacid;NK 104;
  • PSA 90.65000
  • LogP 4.51810

Pitavastatin Specification

This chemical is called Pitavastatin, and its IUPAC name is (E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid. With the molecular formula of C25H24FNO4, its molecular weight is 421.46. The CAS registry number of this chemical is 147511-69-1, and its classification codes are Antihyperlipidemic; Enzyme Inhibitors. 

Other characteristics of the Pitavastatin can be summarised as followings: (1)ACD/LogP: 3.34; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 1.92; (4)ACD/LogD (pH 7.4): 0.22; (5)ACD/BCF (pH 5.5): 7.79; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 59.84; (8)ACD/KOC (pH 7.4): 1.18; (9)#H bond acceptors: 5; (10)#H bond donors: 3; (11)#Freely Rotating Bonds: 10; (12)Polar Surface Area: 57.65 Å2; (13)Index of Refraction: 1.679; (14)Molar Refractivity: 117.77 cm3; (15)Molar Volume: 311.6 cm3; (16)Polarizability: 46.68×10-24cm3; (17)Surface Tension: 64.7 dyne/cm; (18)Density: 1.352 g/cm3; (19)Flash Point: 372.3 °C; (20)Enthalpy of Vaporization: 106.48 kJ/mol; (21)Boiling Point: 692 °C at 760 mmHg; (22)Vapour Pressure: 4.21E-20 mmHg at 25°C.

Uses of this chemical: Like the other statins, pitavastatin is indicated for hypercholesterolaemia (elevated cholesterol) and for the prevention of cardiovascular disease. It can consistently increase HDL cholesterol (10–25%), especially in patients with HDL lower than 40 mg/dl. As a consequence, this chemical is most likely to be appropriate for patients with metabolic syndrome with high LDL, low HDL and diabetes mellitus.

This chemical may cause the side-effects like headaches, stomach upset, abnormal liver function tests and muscle cramps. However, it seems to lead to less muscle side effects than other statins.

You can still convert the following datas into molecular structure: 
1.SMILES: O=C(O)CC(O)CC(O)/C=C/c1c(c3ccccc3nc1C2CC2)c4ccc(F)cc4
2.InChI: InChI=1/C25H24FNO4/c26-17-9-7-15(8-10-17)24-20-3-1-2-4-22(20)27-25(16-5-6-16)21(24)12-11-18(28)13-19(29)14-23(30)31/h1-4,7-12,16,18-19,28-29H,5-6,13-14H2,(H,30,31)/b12-11+
3.InChIKey: VGYFMXBACGZSIL-VAWYXSNFBA

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View